ATE534908T1 - Verfahren und verbindungen zur diagnose und behandlung von krebs - Google Patents
Verfahren und verbindungen zur diagnose und behandlung von krebsInfo
- Publication number
- ATE534908T1 ATE534908T1 AT09167060T AT09167060T ATE534908T1 AT E534908 T1 ATE534908 T1 AT E534908T1 AT 09167060 T AT09167060 T AT 09167060T AT 09167060 T AT09167060 T AT 09167060T AT E534908 T1 ATE534908 T1 AT E534908T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer
- histone
- lysine
- treatment
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/11—Protein-serine/threonine kinases (2.7.11)
- C12Y207/11013—Protein kinase C (2.7.11.13)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09167060A EP2282208B1 (de) | 2009-08-03 | 2009-08-03 | Verfahren und Verbindungen zur Diagnose und Behandlung von Krebs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE534908T1 true ATE534908T1 (de) | 2011-12-15 |
Family
ID=41459776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09167060T ATE534908T1 (de) | 2009-08-03 | 2009-08-03 | Verfahren und verbindungen zur diagnose und behandlung von krebs |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20120329854A1 (de) |
| EP (1) | EP2282208B1 (de) |
| AT (1) | ATE534908T1 (de) |
| WO (1) | WO2011015593A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020041691A1 (en) * | 2018-08-24 | 2020-02-27 | City Of Hope | Oligonucleotide inhibitors of nuclear factor kappa-light-chain-enhancer |
| PL4070111T3 (pl) * | 2019-12-02 | 2025-02-03 | Belgian Volition Srl | Zastosowanie wolnych pozakomórkowych nukleosomsów jako biomarkerów |
| JP7454756B2 (ja) * | 2019-12-05 | 2024-03-25 | 国立大学法人九州大学 | がんを診断するための方法、がん診断用組成物、がん診断用キット、がんの状態を評価する方法、並びにがん予防薬及び/又は治療薬をスクリーニングする方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8008071B2 (en) * | 1999-11-08 | 2011-08-30 | University Of South Florida | Compositions and methods for detecting intracellular glucose and analogs thereof |
| DK2017621T3 (da) * | 2007-07-16 | 2011-08-29 | Universitaetsklinikum Freiburg | Fremgangsmåde til at forudsige ondartetheden af prostatakræft ved detektering af ekspressionen af den proteinkinase-C-relaterede kinase, PRK1 |
-
2009
- 2009-08-03 EP EP09167060A patent/EP2282208B1/de not_active Not-in-force
- 2009-08-03 AT AT09167060T patent/ATE534908T1/de active
-
2010
- 2010-08-03 US US13/388,940 patent/US20120329854A1/en not_active Abandoned
- 2010-08-03 WO PCT/EP2010/061317 patent/WO2011015593A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2282208A1 (de) | 2011-02-09 |
| EP2282208B1 (de) | 2011-11-23 |
| WO2011015593A1 (en) | 2011-02-10 |
| US20120329854A1 (en) | 2012-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE483705T1 (de) | (lh-ind0l-7-yl)-(pyrimidin-2 -yl-amino) methanon derivate und verwandte verbindungen als igf-rl inhibitoren zur behandlung von krebs | |
| MX2012002542A (es) | Compuestos y composiciones como inhibidores de cinasa de proteina. | |
| UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
| CL2011001967A1 (es) | Compuestos derivados de carboxamida-azaheterociclica sustituida, inhibidores de p70s6k, proceso de preparacion de estos; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias y cancer; kit farmaceutico. | |
| DK1853602T3 (da) | Kemiske forbindelser | |
| ATE398613T1 (de) | Chemische verbindungen | |
| BRPI0813625A2 (pt) | Imidazo-[1,2b]-piridozinas 2,3,7-substituídos para tratamento de doenças mediadas por alzk4 ou alk5 | |
| UA102867C2 (uk) | Антитіла до cxcr4 та їх застосування у лікуванні раку | |
| MX2012003311A (es) | Inhibidores de miristato de moleculas pequeñas contra bcr-abl y metodos de uso. | |
| UA95644C2 (ru) | Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний | |
| MX2010003685A (es) | Analogos de quinolona y metodos relacionados con los mismos. | |
| SG171690A1 (en) | Treatment of protein degradation disorders | |
| JO3172B1 (ar) | تركيبة وطريقة وتحضير الصفراء الصناعية | |
| CL2008000020A1 (es) | Compuestos derivados de 2,4-dianilinopirimidinas sustituidas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y tumores malignos. | |
| MX346950B (es) | Reovirus que tienen secuencias modificadas. | |
| MX385354B (es) | Sales de xantilio 3,6-disustituidas. | |
| EA200970065A1 (ru) | Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38 | |
| DE602007010447D1 (de) | Verwendung von 4,17-beta-dihydroxyandrost-4-en-3-on zur behandlung von krebs | |
| ATE543494T1 (de) | Griseofulvin-analoga zur behandlung von krebs durch hemmung von zentrosomaler clusterbildung | |
| MY152018A (en) | Indole derivatives as anticancer agents | |
| BR112017005242A2 (pt) | composto, composição farmacêutica, e, composto para uso. | |
| NO20090402L (no) | Glysintransportor-1-inhibitorer | |
| ATE500236T1 (de) | Mit lanthionin verwandte verbindungen zur behandlung entzündlicher krankheiten | |
| CL2012001579A1 (es) | Compuestos derivados de (heterociclo-piperidina condensada)-(piperazinil) 1-alcanona o de (heterociclo-pirrolidina condensada)-(piperazinil)-1 alcanona, inhibidores de p75; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades neurodegenerativas, esquizofrenia, entre otras; compuesto intermediario. | |
| ATE534908T1 (de) | Verfahren und verbindungen zur diagnose und behandlung von krebs |